Eli Glezer
Founder bei SINGULAR GENOMICS SYSTEMS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Dr. Eli Glezer is a Chief Scientific Officer at Singular Genomics Systems, Inc. Dr. Glezer was previously employed as a Chief Technology Officer by Meso Scale Diagnostics LLC.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Harvard University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
15.03.2024 | 4 585 000 ( 6,20% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Eli Glezer
Unternehmen | Position | Beginn |
---|---|---|
SINGULAR GENOMICS SYSTEMS, INC. | Founder | 01.06.2016 |
Ehemalige bekannte Positionen von Eli Glezer
Unternehmen | Position | Ende |
---|---|---|
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
Ausbildung von Eli Glezer
Harvard University | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SINGULAR GENOMICS SYSTEMS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Health Technology |